Article

Gene-expression profiles and age of donor kidney biopsies obtained before transplantation distinguish medium term graft function.

Department of Nephrology, KH Elisabethinen Linz, and Medical University of Vienna, Vienna, Austria.
Transplantation (Impact Factor: 3.78). 04/2007; 83(8):1048-54. DOI: 10.1097/01.tp.0000259960.56786.ec
Source: PubMed

ABSTRACT Donor factors such as age profoundly influence long-term graft function after cadaveric renal transplantation, but the molecular signature of these aspects in the allograft remains unknown.
We analyzed the genome-wide gene expression signature of donor kidney biopsies of different ages obtained before transplantation. Subsequent analysis compared expression profiles from allografts with excellent function versus impaired function at 1 yr after engraftment. Differential expression profiles were analyzed on the level of molecular function and biologic role, as well as by analysis of co-regulation through transcription factors, regulatory networks, and protein-protein interaction data utilizing extended bioinformatics.
The 15 subjects with excellent transplant function defined as calculated GFR>or=45 mL/min/1.73 m2 at 1 yr exhibited a distinctly different gene expression profile than the matched 16 subjects with impaired function defined as calculated GFR<45 mL/min/1.73 m2. Donor kidneys from recipients with impaired allograft function showed activation of genes mainly belonging to the functional classes of immunity, signal transduction, and oxidative stress response. Two-thirds of these genes exhibited at least one protein interacting partner, suggesting choreographed intracellular events differentiating the two recipient groups. However, donor age may have confounded some of the associations found between gene profiles and graft function.
In summary, a distinctive gene expression profile in the donor kidney at transplantation together with donor age predicts medium term allograft function in recipients of cadaveric allografts.

0 Bookmarks
 · 
76 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Conflicting results have been reported regarding the effects of donor age, recipient age and donor-recipient age difference on short- and long-term outcomes after kidney transplantation. The aim of this study was to evaluate the effects of recipient age on graft function, oxidative stress, and gene expression after renal transplantation. Fifty male Fischer 344 rats [25 young (Y, 4 months), 25 senior (S, 16 months)] were randomized to 6 groups: 2 sham groups (Y and S, n = 5 in each group) and 4 renal transplant groups[young-to-young (Y-Y), young-to-senior (Y-S), senior-to-young (S-Y), senior-to-senior (S-S), (n = 10 in each group)]. The left kidneys were transplanted from donor to recipient. After 12 weeks, systematic blood pressure, graft weight, graft function, histology and oxidative stress were measured. Microarray analysis and quantitative real-time PCR confirmation were performed to study gene expression in the grafts. There were no differences in renal graft function between young and senior kidney cross-transplantation. Transplanted kidneys showed no significant differences in glomerulosclerosis index compared to non-transplanted kidneys but had significantly different tubulointerstitium scores compared to age-matched controls. Senior rats had lower SOD activity and higher MDA content than young rats. SOD activity was significantly lower and MDA content significantly higher in the Y-S group than in the Y-Y group. There were 548 transcript differences between senior and young kidneys with 36 upregulated and 512 downregulated transcripts. There were 492 transcript differences between Y-S and Y-Y groups with 127 upregulated and 365 downregulated transcripts. There were 1244 transcript differences between the S-Y and S-S groups with 680 upregulated and 574 downregulated transcripts. Oxidative stress and gene expression profile was significantly different in the Y-S compared to the S-Y group. The identified differences were mainly in the MAPK and insulin signal pathways, making these potential targets for therapeutic intervention.
    PLoS ONE 06/2013; 8(6):e65613. · 3.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Zusammenfassung Die perkutane Nierenbiopsie stellt derzeit den Goldstandard in der Diagnostik der meisten primären und sekundären Nierenerkrankungen dar. Sie dient der Identifikation und Klassifikation renaler Erkrankungen und ist die Grundlage für die Durchführung standardisierter Therapiekonzepte. Wie bei jeder anderen diagnostischen Technik hängt die Güte der ableitbaren Informationen von der vorhandenen Erfahrung und einer standardisierten Durchführung ab. Für die Nierenbiopsie sind dies v. a. die Gewinnung und adäquate Aufarbeitung von repräsentativem Nierengewebe. Die hierfür notwendigen Vorgehensweisen werden im vorliegenden Artikel genauer dargestellt und diskutiert.
    Der Pathologe 11/2011; · 0.64 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Die perkutane Nierenbiopsie stellt derzeit den Goldstandard in der Diagnostik der meisten primären und sekundären Nierenerkrankungen dar. Sie dient der Identifikation und Klassifikation renaler Erkrankungen und ist die Grundlage für die Durchführung standardisierter Therapiekonzepte. Wie bei jeder anderen diagnostischen Technik hängt die Güte der ableitbaren Information von der vorhandenen Erfahrung und einer standardisierten Durchführung ab. Für die Nierenbiopsie sind dies v. a. die Gewinnung und adäquate Aufarbeitung von repräsentativem Nierengewebe.
    Der Nephrologe 05/2008; 3(3).